Venner P - Search Results

1

A phase 2 study of patupilone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Canadian Urologic Oncology Group study P07a.

Chi KN, Beardsley E, Eigl BJ, Venner P, Hotte SJ, Winquist E, Ko YJ, Sridhar SS, Weber D, Saad F. Chi KN, et al. Among authors: venner p. Ann Oncol. 2012 Jan;23(1):53-58. doi: 10.1093/annonc/mdr336. Epub 2011 Jul 16. Ann Oncol. 2012. PMID: 21765178 Free article. Clinical Trial.

2

Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group.

Gleave ME, Elhilali M, Fradet Y, Davis I, Venner P, Saad F, Klotz LH, Moore MJ, Paton V, Bajamonde A. Gleave ME, et al. Among authors: venner p. N Engl J Med. 1998 Apr 30;338(18):1265-71. doi: 10.1056/NEJM199804303381804. N Engl J Med. 1998. PMID: 9562580 Free article. Clinical Trial.

3

Increased survival with enzalutamide in prostate cancer after chemotherapy.

Scher HI, Fizazi K, Saad F, Taplin ME, Sternberg CN, Miller K, de Wit R, Mulders P, Chi KN, Shore ND, Armstrong AJ, Flaig TW, Fléchon A, Mainwaring P, Fleming M, Hainsworth JD, Hirmand M, Selby B, Seely L, de Bono JS; AFFIRM Investigators. Scher HI, et al. N Engl J Med. 2012 Sep 27;367(13):1187-97. doi: 10.1056/NEJMoa1207506. Epub 2012 Aug 15. N Engl J Med. 2012. PMID: 22894553 Free article. Clinical Trial.

4

Placebo-associated remissions in a multicentre, randomized, double-blind trial of interferon gamma-1b for the treatment of metastatic renal cell carcinoma. The Canadian Urologic Oncology Group.

Elhilali MM, Gleave M, Fradet Y, Davis I, Venner P, Saad F, Klotz L, Moore R, Ernst S, Paton V. Elhilali MM, et al. Among authors: venner p. BJU Int. 2000 Oct;86(6):613-8. doi: 10.1046/j.1464-410x.2000.00880.x. BJU Int. 2000. PMID: 11069364 Clinical Trial.

5

Enzalutamide in metastatic prostate cancer before chemotherapy.

Beer TM, Armstrong AJ, Rathkopf DE, Loriot Y, Sternberg CN, Higano CS, Iversen P, Bhattacharya S, Carles J, Chowdhury S, Davis ID, de Bono JS, Evans CP, Fizazi K, Joshua AM, Kim CS, Kimura G, Mainwaring P, Mansbach H, Miller K, Noonberg SB, Perabo F, Phung D, Saad F, Scher HI, Taplin ME, Venner PM, Tombal B; PREVAIL Investigators. Beer TM, et al. Among authors: venner pm. N Engl J Med. 2014 Jul 31;371(5):424-33. doi: 10.1056/NEJMoa1405095. Epub 2014 Jun 1. N Engl J Med. 2014. PMID: 24881730 Free PMC article. Clinical Trial.

6

Randomized, double-blind, placebo-controlled trial of epoetin alfa in men with castration-resistant prostate cancer and anemia.

Winquist E, Julian JA, Moore MJ, Nabid A, Sathya J, Wood L, Venner P, Levine M. Winquist E, et al. Among authors: venner p. J Clin Oncol. 2009 Feb 1;27(4):644-6. doi: 10.1200/JCO.2008.20.4966. Epub 2008 Dec 22. J Clin Oncol. 2009. PMID: 19103725 Clinical Trial. No abstract available.

7

Gemcitabine in advanced renal cell carcinoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group.

Mertens WC, Eisenhauer EA, Moore M, Venner P, Stewart D, Muldal A, Wong D. Mertens WC, et al. Among authors: venner p. Ann Oncol. 1993 Apr;4(4):331-2. doi: 10.1093/oxfordjournals.annonc.a058494. Ann Oncol. 1993. PMID: 8518225 Free article. Clinical Trial.

8

Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer.

Moore MJ, Osoba D, Murphy K, Tannock IF, Armitage A, Findlay B, Coppin C, Neville A, Venner P, Wilson J. Moore MJ, et al. Among authors: venner p. J Clin Oncol. 1994 Apr;12(4):689-94. doi: 10.1200/JCO.1994.12.4.689. J Clin Oncol. 1994. PMID: 7512127 Clinical Trial.

9

Megestrol acetate in the treatment of metastatic carcinoma of the prostate.

Venner P. Venner P. Oncology. 1992;49 Suppl 2:22-7. doi: 10.1159/000227123. Oncology. 1992. PMID: 1461622 Review.

10

Phase II study of sulofenur (LY186641) in measurable metastatic renal cancer.

Weinerman B, Eisenhauer E, Stewart D, Mertens W, Tannock I, Venner P, Spaulding R. Weinerman B, et al. Among authors: venner p. Ann Oncol. 1992 Jan;3(1):83-4. doi: 10.1093/oxfordjournals.annonc.a058081. Ann Oncol. 1992. PMID: 1606075 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters